Dim - NutraPedia

Back to Table of Contents

Diindolylmethane (DIM) Overview

1) Conditions Diindolylmethane Has Been Studied For

  • Hormonal balance and estrogen metabolism
  • Preventive effects on cancer, particularly breast, uterine, and colorectal cancers
  • Prostate health
  • Anti-inflammatory effects
  • Support for weight loss and metabolism
  • Immune system enhancement

2) Efficacy in Treating Conditions

Research findings are mixed, and while some studies suggest potential benefits, especially in the context of cancer prevention and hormone-related disorders, definitive conclusions on its efficacy are still pending further clinical trials. Therefore, DIM should not be considered a definitive treatment for the listed conditions.

3) Health Benefits of Diindolylmethane

  • May promote healthy estrogen metabolism
  • Potential anti-carcinogenic properties
  • Could support immune function
  • May have anti-inflammatory effects
  • Possible assistance in weight management

4) Downsides of Diindolylmethane

  • Gastrointestinal discomfort in some individuals
  • Potential for drug interactions
  • Limited long-term safety data
  • May affect hormone-sensitive conditions negatively

5) Impact on Specific Genetic Variations

Research on DIM's effects on particular genetic variations is ongoing. Some evidence suggests that individuals with certain genetic polymorphisms that affect estrogen metabolism may experience different effects from DIM supplementation. However, more research is needed to make conclusive statements about the benefits or harms of DIM for specific genetic variations.

Effects of 3,3'-Diindolylmethane (DIM) on Cancer Cells

Antagonistic to Synergistic Interaction: DIM, combined with sulforaphane (SFN), showed antagonistic effects at low concentrations, reducing their effectiveness in inhibiting cell proliferation. At higher concentrations, this interaction became synergistic, enhancing cell growth inhibition in human colon cancer cells.

Cell Cycle Arrest: A 1:1 combination of SFN and DIM at 20 microM concentration resulted in a strong arrest of the cell cycle in the G2/M phase in colon carcinoma cells, an effect not observed with either compound alone.

DIM's Biological Activity and Metabolism

Activation of Liver Enzymes: DIM was identified as a product of I3C under acidic conditions and was found to induce liver enzymes involved in detoxification, suggesting a potential cancer-preventive effect.

Formation in Acidic Conditions: Studies revealed that DIM forms under acidic conditions, such as those in the stomach, and can induce enzymes that break down toxins.

Interactions with Hormone Receptors and Pathways

Activation of Estrogen Receptor Alpha (ERα): At low concentrations, DIM activated ERα signaling, promoting cell proliferation in human breast cancer cell lines. At higher concentrations, it inhibited cell proliferation.

Impact on Estrogen Metabolism: DIM influenced the metabolism of estrogen, potentially affecting estrogen-dependent cancer risk.

Effects on Androgen Receptor: DIM acted as an androgen receptor antagonist in prostate cancer cells, inhibiting cell growth and reducing dihydrotestosterone (DHT) effects.

DIM's Role in Chemoprevention

Induction of Cytochrome P450 Enzymes: DIM induced the activity of enzymes that metabolize estrogen, which may contribute to its protective effects against hormone-dependent cancers.

Inhibition of Tumor Formation: DIM inhibited tumor formation in rodents when administered before exposure to carcinogens, highlighting its potential chemopreventive properties.

Stimulation of Interferon-gamma: DIM increased the expression and secretion of interferon-gamma in human breast cancer cells, which plays a role in inhibiting tumor development.

Conclusion

DIM, derived from cruciferous vegetables, exhibits a range of effects on cancer cells, including the inhibition of cell proliferation, interaction with hormone receptors, and the activation of detoxification enzymes. At varying concentrations, DIM can both stimulate and inhibit cancer cell growth, suggesting a complex role in cancer prevention and treatment.

References:


  1. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives
  2. Quantitative combination effects between sulforaphane and 3,3'-diindolylmethane on proliferation of human colon cancer cells in vitro
  3. Structure-activity relationships of dietary indoles: a proposed mechanism of action as modifiers of xenobiotic metabolism
  4. Oligomerization of indole-3-carbinol in aqueous acid
  5. Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro
  6. Development of a food composition database for the estimation of dietary intakes of glucosinolates, the biologically active constituents of cruciferous vegetables
  7. Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans
  8. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli
  9. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables
  10. Hydrolysis of glucosinolates to isothiocyanates after ingestion of raw or microwaved cabbage by human volunteers
  11. Glucosinolates and myrosinase activity in red cabbage (Brassica oleracea L. var. Capitata f. rubra DC.) after various microwave treatments
  12. Changes in glucosinolate concentrations, myrosinase activity, and production of metabolites of glucosinolates in cabbage (Brassica oleracea Var. capitata) cooked for different durations
  13. Effect of storage, processing and cooking on glucosinolate content of Brassica vegetables
  14. Indole-3-carbinol as a chemopreventive and anti-cancer agent
  15. The major cyclic trimeric product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway
  16. Antiobesity activities of indole-3-carbinol in high-fat-diet-induced obese mice
  17. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor
  18. Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol
  19. A new class of estrogen receptor beta-selective activators
  20. Potent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways
  21. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression
  22. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells
  23. Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention
  24. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats
  25. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles
  26. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation
  27. Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or beta-naphthaflavone: a comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods
  28. 2-hydroxyestrone: the 'good' estrogen
  29. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer
  30. DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism
  31. The ATM-dependent DNA damage signaling pathway
  32. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A
  33. BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane
  34. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol
  35. Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells
  36. 3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status
  37. Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells
  38. DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways
  39. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates
  40. 3,3'-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans
  41. 3,3'-Diindolylmethane Promotes BDNF and Antioxidant Enzyme Formation via TrkB/Akt Pathway Activation for Neuroprotection against Oxidative Stress-Induced Apoptosis in Hippocampal Neuronal Cells
  42. Regulating miRNA by natural agents as a new strategy for cancer treatment
  43. Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia
  44. The mTOR signalling pathway in cancer and the potential mTOR inhibitory activities of natural phytochemicals
  45. Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells
  46. Strain-specific altered nicotine metabolism in 3,3'-diindolylmethane (DIM) exposed mice
  47. Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic
  48. Targeting the Microcirculation by Indole-3-carbinol and Its Main Derivate 3,3,'-diindolylmethane: Effects on Angiogenesis, Thrombosis and Inflammation
  49. An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases
  50. 3,3'-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices
  51. 3,3'-diindolylmethane inhibits LPS-induced human chondrocytes apoptosis and extracellular matrix degradation by activating PI3K-Akt-mTOR-mediated autophagy
  52. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer
  53. A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF-α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT/mTOR Signal Pathway
  54. 3,3 diindolylmethane leads to apoptosis, decreases sperm quality, affects blood estradiol 17 β and testosterone, oestrogen (α and β) and androgen receptor levels in the reproductive system in male rats
  55. Retraction: Down-regulation of Androgen Receptor by 3,3'-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Both Hormone-Sensitive LNCaP and Insensitive C4-2B Prostate Cancer Cells
  56. Hormonal Regulation In Pcos Using Acupuncture And Herbal Supplements: A Case Report And Review Of The Literature
  57. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats
  58. Indole-3-carbinol, but not its major digestive product 3,3'-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450
  59. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells
  60. Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3'-diindolylmethane and its parent compound indole-3-carbinol
  61. The Anticancer Agent 3,3'-Diindolylmethane Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and Candida albicans
  62. Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR
  63. Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal Cancer
  64. DIMming ovarian cancer growth
  65. The anticarcinogen 3,3'-diindolylmethane is an inhibitor of cytochrome P-450
  66. Attenuation of Carcinogenesis and the Mechanism Underlying by the Influence of Indole-3-carbinol and Its Metabolite 3,3'-Diindolylmethane: A Therapeutic Marvel
  67. A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges


Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!